市场调查报告书
商品编码
1497764
采血管市场:按产品类型、材料类型和最终用户划分 - 全球预测 2024-2030Blood Collection Tubes Market by Product Type (EDTA Tubes, Heparin Tubes, Plasma Separation Tube), Material Type (Glass, Plastic), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年采血管市场规模为27.1亿美元,预计2024年将达29.4亿美元,2030年将达46.8亿美元,复合年增长率为8.10%。
Investigation_KEYWORD 是一种用于收集、储存和运输血液样本的设备,用于各种临床应用,包括诊断、输血、研究、药物发现、基因分析和法医学。由于人口老化需要定期对慢性疾病进行血液检查,以及对早期诊断和预防性医疗措施的需求不断增加,采血管的采用不断增加。真空管技术的进一步进步可确保在最小污染的情况下准确提取样品、实验室工作流程自动化以及公众定期健康检查的意识正在支持市场需求。然而,有关产品品质标准的严格监管准则以及样品处理过程中交叉污染的风险正在阻碍市场成长。除此之外,改进储存解决方案的材料进步、提高照护现场诊断准确性的生物标记物整合以及支援物联网的智慧管的开拓预计将为市场创造机会主义局面。
主要市场统计 | |
---|---|
基准年[2023] | 27.1亿美元 |
预测年份 [2024] | 29.4亿美元 |
预测年份 [2030] | 46.8亿美元 |
复合年增长率(%) | 8.10% |
区域洞察
在美洲,人口老化的加剧导致慢性病盛行率的增加,导致采血管的使用增加。此外,该地区在医疗保健旅游和早期疾病诊断方面的支出能力强劲。在EMEA地区,医疗基础设施发达,主要製造商的存在增加了产品改进的研发成本,这正在支持市场开拓。此外,在欧洲、中东和非洲地区,由于医疗保健投资的增加,中东和非洲为采血管产品提供了潜在的成长机会。各国政府正在鼓励官民合作关係来改善卫生基础设施,这可以增加对采血管等高品质诊断产品的需求。亚太地区由于人口众多,需要采血管作为诊断用管,因此市场前景良好。该地区新兴经济体医疗保健产业的开拓,以及政府致力于提供无障碍医疗保健服务的倡议,预计将支持市场成长。
FPNV定位矩阵
FPNV定位矩阵对于评估供应商在采血管市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对采血管市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析也为该领域的竞争性质提供了宝贵的见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在采血管市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The Blood Collection Tubes Market size was estimated at USD 2.71 billion in 2023 and expected to reach USD 2.94 billion in 2024, at a CAGR 8.10% to reach USD 4.68 billion by 2030.
Blood collection tubes are the devices used for collecting, storing, and transporting blood samples in various clinical applications, including diagnostics, transfusions, research studies, drug discovery, genetic profiling, and forensic science. The aging population requiring regular blood tests for chronic diseases and increased demand for early diagnosis and preventive healthcare measures have increased the adoption of blood collection tubes. Further advancements in vacuum tube technology ensuring accurate sample extraction with minimal contamination, automation in laboratory workflows, and public awareness leading to regular medical check-ups have supported the market demand. However, stringent regulatory guidelines on product quality standards and cross-contamination risks during sample handling procedures hinder market growth. Apart from this, material advancements for improved storage solutions, biomarker integration to enhance diagnostic accuracy at point-of-care, and the development of IoT-enabled smart tubes are expected to create an opportunistic landscape for the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.71 billion |
Estimated Year [2024] | USD 2.94 billion |
Forecast Year [2030] | USD 4.68 billion |
CAGR (%) | 8.10% |
Regional Insights
In the Americas region, the increasing geriatric population leading to the prevalence of chronic diseases has increased the use of blood collection tubes. Moreover, healthcare tourism and spending capabilities for early disease diagnostics have flourished in this region. In the EMEA region, well-developed healthcare infrastructure and the presence of the major manufacturers leading to increased spending on research & development for product improvements have supported the market demand. Further, In the EMEA region, the Middle East and Africa demonstrate potential growth opportunities for blood collection tube products due to increasing healthcare investments in these regions. Governments are encouraging public-private partnerships to improve medical infrastructure, which may increase the demand for quality diagnostic products such as blood collection tubes. Asia Pacific region showcased an opportunistic landscape for the market in the face of large population countries requiring blood collection tubes for diagnostic tubes. The developing healthcare sector across the many economies in the region, along with government initiatives focusing on providing accessible healthcare services, is expected to support the market growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Blood Collection Tubes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Collection Tubes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Collection Tubes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Husky Installs First-of-Its-Kind Medical Molding System in India
Husky implemented a state-of-the-art medical molding system in India, marking a significant milestone in the industry. This innovative system is designed exclusively for the production of blood collection tubes, catering to the specific needs of the medical sector. With the integration of an all-electric injection molding machine and two adjacent Husky HyPET HPP5 systems, the system streamlines and optimizes the entire production cycle. [Published On: 2023-06-02]
CML Biotech installs integrated blood collection tube manufacturing machine
CML Biotech introduced integrated blood collection tube manufacturing machine. This cutting-edge machine is capable of completing multiple processes in one go, including the production of plastic molds and the filling of tubes with additives. By automating these tasks, CML Biotech expects to achieve significant cost savings of 25-30% in labor expenses, while also improving overall efficiency by 30-35%. Moreover, this innovative machine has been meticulously designed to adhere to high product quality and safety standards, ensuring the utmost reliability for medical professionals and patients alike. [Published On: 2023-05-27]
MHT Mold & Hotrunner Technology and KEBO Partner on Blood Collection Tubes (BCT)
MHT Mold & Hotrunner Technology (MHT) and KEBO have formed a strategic partnership to introduce a new product line, Blood Collection Tubes (BCT). MHT's automated mold system is seamlessly integrated with KEBO's medical-grade operatory management system, ensuring utmost accuracy and quality. This collaboration provides healthcare facilities with a cost-effective and reliable solution for the safe collection, storage, and transportation of blood samples. [Published On: 2023-01-26]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Collection Tubes Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Blood Collection Tubes Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Becton, Dickinson & Company, Bioscientia Healthcare, Biosigma S.p.A., Cardinal Health, Inc., CML BIOTECH LIMITED, Convergent Technologies GmbH, FL Medical S.R.L., Greiner Bio One International Gmbh, Guangzhou Improve Medical Instruments Co. Ltd., Haemonetics Corporation, Labtech S.r.l., Medtronic plc, Micsafe Medical Group, Nanjing Vazyme Medical Technology Co., Ltd., Nipro Medical Corporation, QIAGEN N.V., Radiometer India, SARSTEDT AG & Co. KG, Smiths Medical, Inc. by ICU Medical, Inc., Sunphoria Co., Ltd., Terumo Corporation, and Vyaire Medical, Inc..
Market Segmentation & Coverage